FI864597A - Kardiotoniska tiazoloner. - Google Patents

Kardiotoniska tiazoloner. Download PDF

Info

Publication number
FI864597A
FI864597A FI864597A FI864597A FI864597A FI 864597 A FI864597 A FI 864597A FI 864597 A FI864597 A FI 864597A FI 864597 A FI864597 A FI 864597A FI 864597 A FI864597 A FI 864597A
Authority
FI
Finland
Prior art keywords
thiazoloner
cardiotonic
thiazolones
cardiotonics
useful
Prior art date
Application number
FI864597A
Other languages
English (en)
Finnish (fi)
Other versions
FI864597A0 (fi
Inventor
Richard A Schnettler
Jr Winton D Jones
George P Claxton
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI864597A0 publication Critical patent/FI864597A0/fi
Publication of FI864597A publication Critical patent/FI864597A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polyurethanes Or Polyureas (AREA)
FI864597A 1985-11-13 1986-11-12 Kardiotoniska tiazoloner. FI864597A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/797,579 US4670450A (en) 1985-11-13 1985-11-13 Cardiotonic thiazolones

Publications (2)

Publication Number Publication Date
FI864597A0 FI864597A0 (fi) 1986-11-12
FI864597A true FI864597A (fi) 1987-05-14

Family

ID=25171231

Family Applications (1)

Application Number Title Priority Date Filing Date
FI864597A FI864597A (fi) 1985-11-13 1986-11-12 Kardiotoniska tiazoloner.

Country Status (21)

Country Link
US (1) US4670450A (fr)
EP (1) EP0223178B1 (fr)
JP (1) JPS62114977A (fr)
KR (1) KR900000370B1 (fr)
CN (1) CN86107814A (fr)
AT (1) ATE79617T1 (fr)
AU (1) AU596616B2 (fr)
CA (1) CA1276936C (fr)
DE (1) DE3686473T2 (fr)
DK (1) DK540586A (fr)
ES (1) ES2034953T3 (fr)
FI (1) FI864597A (fr)
GR (1) GR3005481T3 (fr)
HU (1) HUT45035A (fr)
IE (1) IE58295B1 (fr)
IL (1) IL80584A0 (fr)
NO (1) NO864514L (fr)
NZ (1) NZ218238A (fr)
PH (1) PH22390A (fr)
PT (1) PT83733B (fr)
ZA (1) ZA868504B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734422A (en) * 1985-10-15 1988-03-29 Merrell Dow Pharmaceuticals Inc. Cardiotonic aroylthiazolones and the use thereof
US4927939A (en) * 1985-10-15 1990-05-22 Merrell Dow Pharmaceuticals Cardiotonic aroylthiazolones
US4868182A (en) * 1986-11-05 1989-09-19 Merrell Dow Pharmaceuticals Inc. Enhancement of prazosin
US4866182A (en) * 1988-02-18 1989-09-12 Merrell Dow Pharmaceuticals Inc. Cardiotonic alkanoyl and aroyl oxazolones
US4886811A (en) * 1988-10-24 1989-12-12 Merrell Dow Pharmaceuticals Qunolyloxazole-2-ones useful as proteinkinase C inhibitors
US4990519A (en) * 1988-10-24 1991-02-05 Merrell Dow Pharmaceuticals Method of using quinolyloxazole-2-ones as proteinkinase C inhibitors
US4999431A (en) * 1988-10-24 1991-03-12 Merrell Dow Pharmaceuticals Process for preparing quinoline aldehyde and ketone derivatives
EP0478195B1 (fr) * 1990-09-21 1999-05-26 Rohm And Haas Company Dihydropyridazinones et pyridazinones comme fongicides
AU645217B2 (en) * 1991-05-14 1994-01-06 Merrell Dow Pharmaceuticals Inc. Inhibition of metastasis in patients having cancer with pyridyloxazole-2-ones
CN1038249C (zh) * 1991-08-28 1998-05-06 罗姆和哈斯公司 含有二氢哒嗪酮及其相关化合物的杀菌组合物
WO2001074811A2 (fr) * 2000-03-30 2001-10-11 Takeda Chemical Industries, Ltd. Composes de 1,3-thiazole substitues, production et utilisation desdits composes

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538104A (en) * 1969-02-28 1970-11-03 Geigy Chem Corp Pyridyl-2-imidazolones
SU427015A1 (ru) * 1972-04-21 1974-05-05 В. М. Дзиомко , А. В. Иващенко Способ получения замещенных 4-оксазолин-2-онов
GB1435139A (en) * 1972-08-17 1976-05-12 Sumitomo Chemical Co Thiazole derivatives
JPS5238559B2 (fr) * 1972-08-17 1977-09-29
US3897410A (en) * 1973-06-04 1975-07-29 Dow Chemical Co Rapid setting non-elastomeric polyurethane compositions prepared in the presence of a mixture of liquid modifiers
JPS5111763A (en) * 1974-07-16 1976-01-30 Sankyo Co 55 chikan 44 okisazorin 22 onno seizoho
JPS5811867B2 (ja) * 1974-11-06 1983-03-04 東京田辺製薬株式会社 ５，５−ジメチル−４−フエニルオキサゾリジン−２−オン誘導体の製造方法
DD127812A1 (de) * 1976-09-14 1977-10-12 Joerg Beger Verfahren zur herstellung von 2-mercapto und 2-alkylmercaptothiazolen
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
IT1109002B (it) * 1977-09-22 1985-12-16 Menarini Sas Derivati del 2 oxazolidone e loro metodi di preparazione
JPS57134417A (en) * 1981-02-14 1982-08-19 Meiji Seika Kaisha Ltd Cardiotonic agent
US4649146A (en) * 1983-01-31 1987-03-10 Fujisawa Pharmaceutical Co., Ltd. Thiazole derivatives and pharmaceutical composition comprising the same
US4532250A (en) * 1983-11-23 1985-07-30 American Hospital Supply Corporation 5-Heteroarylimidazol-2-ones having cardiotonic activity
US4623651A (en) * 1985-10-15 1986-11-18 Merrell Dow Pharmaceuticals Inc. Cardiotonic heterocyclocarbonyl- and acetyl-thiazolones
US4698353A (en) * 1985-11-13 1987-10-06 Merrell Dow Pharmaceuticals Inc. Cardiotonic heterocyclic oxazolones

Also Published As

Publication number Publication date
AU596616B2 (en) 1990-05-10
NZ218238A (en) 1989-07-27
GR3005481T3 (fr) 1993-05-24
DE3686473T2 (de) 1993-01-28
NO864514D0 (no) 1986-11-12
IE862991L (en) 1987-05-13
KR900000370B1 (ko) 1990-01-25
IL80584A0 (en) 1987-02-27
NO864514L (no) 1987-05-14
DK540586A (da) 1987-05-14
KR870004971A (ko) 1987-06-02
ATE79617T1 (de) 1992-09-15
FI864597A0 (fi) 1986-11-12
PH22390A (en) 1988-08-12
ZA868504B (en) 1987-06-24
DK540586D0 (da) 1986-11-12
AU6493386A (en) 1987-05-21
CA1276936C (fr) 1990-11-27
EP0223178B1 (fr) 1992-08-19
CN86107814A (zh) 1987-09-30
DE3686473D1 (de) 1992-09-24
HUT45035A (en) 1988-05-30
US4670450A (en) 1987-06-02
ES2034953T3 (es) 1993-04-16
PT83733A (en) 1986-12-01
EP0223178A1 (fr) 1987-05-27
JPS62114977A (ja) 1987-05-26
PT83733B (pt) 1988-08-17
IE58295B1 (en) 1993-08-25

Similar Documents

Publication Publication Date Title
AU557590B2 (en) Aroylimidazolones
FI864597A (fi) Kardiotoniska tiazoloner.
ES2000594A6 (es) Un procedimiento para la preparacion de tiazolonas
DE3686472D1 (de) Cardiotonische phenyloxazolone.
DE3662694D1 (en) Hydrosoluble copolymers and their use as building material auxiliaries
DE3581979D1 (de) Elektronenstrahlbehandlung zum erhoehen des haftvermoegens von polyesterfilmen.
CA1266268C (fr) Aroylthiazolones cardiotoniques
DE68911944D1 (de) Cardiotonische Alkanoyl- und Aroyloxazole.
FI871737A0 (fi) Kraftanlaeggning med foerbraenning i en fluidiserad baedd.
UA13708A1 (uk) Кріопротектор
ES8507116A1 (es) Un procedimiento para preparar un alcoxiimino eter

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: MERRELL DOW PHARMACEUTICALS INC.